Innovative Therapies Targeting Drug-Resistant Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma (ccRCC).

Int J Mol Sci · 2024 · PMC11720203 · PMID 39796121

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an interesting trendno p-value reported

An analysis utilizing the BTLA TIMER Database uncovered an interesting trend: in Papillary Renal Cell Carcinoma (PRCC), BTLA expression is notably higher in cancer cells than in the adjacent healthy tissues [ 77 , 78 , 79 ].

also in 765 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.